This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Yoshiaki Horiguchi: Innovator in Pharmaceutical Chemistry
Introduction
Yoshiaki Horiguchi is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential.
Latest Patents
Horiguchi holds a patent for a 6-azaindole compound. This compound is represented by a specific formula where R, R, and R can be hydrogen atoms or various substituents. Notably, one of the R groups is a hydrogen atom while the other is a group that can be represented by the formula: —C(≡X)—R, where X can be N—O—R or N—NH—R. This compound exhibits superior IκB kinase inhibitory activity, making it useful as a pharmaceutical agent for preventing or treating diabetes and other related conditions. He has 1 patent to his name.
Career Highlights
Horiguchi is associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His work focuses on innovative solutions to address various health challenges through advanced chemical compounds.
Collaborations
Throughout his career, Horiguchi has collaborated with notable colleagues, including Hiroshi Imoto and Mark Allan Wolf. These collaborations have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Yoshiaki Horiguchi is a key figure in pharmaceutical innovation, with a focus on compounds that have the potential to improve health outcomes. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile